Log in
Enquire now
Vor BioPharma

Vor BioPharma

Vor BioPharma is a biotechnology company developing hematopoietic stem cell therapy treatments for cancer.

OverviewStructured DataIssuesContributors

Contents

vorbio.com
vorbiopharma.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Biotechnology
Biotechnology
Regenerative medicine
Regenerative medicine
Gene therapy
Gene therapy
Genomics
Genomics
‌
Genome editing
Cell therapy
Cell therapy
Stem cell
Stem cell
...
Location
Massachusetts
Massachusetts
Cambridge, Massachusetts
Cambridge, Massachusetts
0
Boston
Boston
United States
United States
CEO
‌
Robert Ang
0
Pitchbook URL
pitchbook.com/profiles...167194-27
Legal Name
Vor Biopharma Inc.0
Legal classification
Public company
Public company
0
Number of Employees (Ranges)
51 – 200
Email Address
info@vorbiopharma.com0
media@vorbio.com0
careers@vorbio.com
Phone Number
+161765565800
Number of Employees
135
Full Address
100 Cambridgepark Dr, Suite 400, Cambridge, Massachusetts 02140, US
100 Cambridgepark Dr Suite 101 Cambridge, MA 021400
CIK Number
1,817,2290
Place of Incorporation
Delaware
Delaware
0
Investors
PureTech
PureTech
RA Capital Management
RA Capital Management
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation
Johnson & Johnson Innovation
Osage University Partners
Osage University Partners
5AM Ventures
5AM Ventures
DUNS Number
0806656870
Founded Date
2015
Total Funding Amount (USD)
194,000,000
Latest Funding Round Date
July 8, 2020
Competitors
Vizgen
Vizgen
Stock Symbol
VOR0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
‌
Matthew R. Patterson
0
‌
Robert Ang
0
‌
Kush Parmar
0
CFO
‌
Nathan Jorgensen
0
Latest Funding Type
Series B
Series B
CAGE Code
7X7G70
Patents Assigned (Count)
1
Technologies Used
CRISPR
CRISPR
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
110,000,000
SIC Code
2,8360
Ticker Symbol
VOR0

Vor BioPharma is a biotechnology company developing hematopoietic stem cell therapy treatments for cancer that is headquartered in Boston, Massachusetts and was founded in 2016 by David Steinberg, Siddhartha Mukherjee, and Aleks Radovic-Moreno.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

How Vor Biopharma's platform could eliminate on-target toxicity for CAR Ts

Jennie Walters

https://www.biocentury.com/bc-innovations/emerging-company-profile/2018-05-17/how-vor-biopharma%E2%80%99s-platform-could-eliminate-

Web

Launch Announcement -- Vor Biopharma

Vor BioPharma

http://www.vorbiopharma.com/puretech-teams-with-siddhartha-mukherjee

Web

Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Business Wire

https://www.businesswire.com/news/home/20190213005927/en/Vor-Biopharma-Completes-42-Million-Series-Financing

Web

References

Find more companies like Vor BioPharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.